KA to use DSM's technology at Togliatti caprolactam plant
25 Jan '11
4 min read
As a result of the license agreement between DSM and KA, DSM will realize royalty income over 15 years. DSM Fibre Intermediates will also participate via drawing rights in part of the increased production capacity of KA.
DSM has proprietary world-class cyclohexanone and caprolactam technologies with multiple licensees worldwide.
The establishment of the joint ventures and related agreements is subject to regulatory approval. Closing of the intended acquisition of the compounding plant is expected in Q1 2011.
KuibyshevAzot OJSC is one of the leading companies of the Russian chemical industry. The company located in Togliatti, Samara region, conducts its business in two areas: production of caprolactam and its derived products (PA-6, high tenacity yarns, cord fabric, engineering plastics) production of ammonia and nitrogen fertilizers.
Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel.
20240830145952.gif)
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "UBM China (Shanghai)")
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
